150 related articles for article (PubMed ID: 38353645)
1. A Systematic Review of the Clinical Effects of Cannabis and Cannabinoids in Posttraumatic Stress Disorder Symptoms and Symptom Clusters.
Rodas JD; George TP; Hassan AN
J Clin Psychiatry; 2024 Feb; 85(1):. PubMed ID: 38353645
[No Abstract] [Full Text] [Related]
2. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
[TBL] [Abstract][Full Text] [Related]
3. Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study.
Bilevicius E; Sommer JL; Asmundson GJG; El-Gabalawy R
Depress Anxiety; 2019 Nov; 36(11):1036-1046. PubMed ID: 31356731
[TBL] [Abstract][Full Text] [Related]
4. Use and effects of cannabinoids in military veterans with posttraumatic stress disorder.
Betthauser K; Pilz J; Vollmer LE
Am J Health Syst Pharm; 2015 Aug; 72(15):1279-84. PubMed ID: 26195653
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use and posttraumatic stress disorder: prospective evidence from a longitudinal study of veterans.
Metrik J; Stevens AK; Gunn RL; Borsari B; Jackson KM
Psychol Med; 2022 Feb; 52(3):446-456. PubMed ID: 32546286
[TBL] [Abstract][Full Text] [Related]
6. Cannabis use disorder and post-traumatic stress disorder: The prevalence of comorbidity in veterans of recent conflicts.
Bryan JL; Hogan J; Lindsay JA; Ecker AH
J Subst Abuse Treat; 2021 Mar; 122():108254. PubMed ID: 33509412
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder.
Livingston NA; Farmer SL; Mahoney CT; Marx BP; Keane TM
Psychol Addict Behav; 2022 Mar; 36(2):131-143. PubMed ID: 34351175
[TBL] [Abstract][Full Text] [Related]
8. Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review.
O'Neil ME; Nugent SM; Morasco BJ; Freeman M; Low A; Kondo K; Zakher B; Elven C; Motu'apuaka M; Paynter R; Kansagara D
Ann Intern Med; 2017 Sep; 167(5):332-340. PubMed ID: 28806794
[TBL] [Abstract][Full Text] [Related]
9. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.
Steenkamp MM; Blessing EM; Galatzer-Levy IR; Hollahan LC; Anderson WT
Depress Anxiety; 2017 Mar; 34(3):207-216. PubMed ID: 28245077
[TBL] [Abstract][Full Text] [Related]
10. Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.
Solmi M; De Toffol M; Kim JY; Choi MJ; Stubbs B; Thompson T; Firth J; Miola A; Croatto G; Baggio F; Michelon S; Ballan L; Gerdle B; Monaco F; Simonato P; Scocco P; Ricca V; Castellini G; Fornaro M; Murru A; Vieta E; Fusar-Poli P; Barbui C; Ioannidis JPA; Carvalho AF; Radua J; Correll CU; Cortese S; Murray RM; Castle D; Shin JI; Dragioti E
BMJ; 2023 Aug; 382():e072348. PubMed ID: 37648266
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program.
Greer GR; Grob CS; Halberstadt AL
J Psychoactive Drugs; 2014; 46(1):73-7. PubMed ID: 24830188
[TBL] [Abstract][Full Text] [Related]
13. Burden of cannabis use and disorder in the U.S. veteran population: Psychiatric comorbidity, suicidality, and service utilization.
Hill ML; Nichter BM; Norman SB; Loflin M; Pietrzak RH
J Affect Disord; 2021 Jan; 278():528-535. PubMed ID: 33017681
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis.
Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L
Lancet Psychiatry; 2019 Dec; 6(12):995-1010. PubMed ID: 31672337
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention.
Mizrachi Zer-Aviv T; Segev A; Akirav I
Behav Pharmacol; 2016 Oct; 27(7):561-9. PubMed ID: 27551883
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset.
Preuss UW; Hesselbrock MN; Hesselbrock VM
Brain Sci; 2023 Jul; 13(8):. PubMed ID: 37626487
[TBL] [Abstract][Full Text] [Related]
17. Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
Stanciu CN; Brunette MF; Teja N; Budney AJ
Psychiatr Serv; 2021 Apr; 72(4):429-436. PubMed ID: 33530732
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans.
Wolfgang AS; Hoge CW
JAMA Psychiatry; 2023 Sep; 80(9):869-870. PubMed ID: 37436761
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use disorder, anger, and violence in Iraq/Afghanistan-era veterans.
Dillon KH; Van Voorhees EE; Elbogen EB; Beckham JC; ; Calhoun PS
J Psychiatr Res; 2021 Jun; 138():375-379. PubMed ID: 33933928
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
